BCL2 Protein Reduces Cell Death and Improves Survival in Sepsis
Author Information
Author(s): Iwata Akiko, de Claro R. Angelo, Morgan-Stevenson Vicki L., Tupper Joan C., Schwartz Barbara R., Liu Li, Zhu Xiaodong, Jordan Katherine C., Winn Robert K., Harlan John M.
Primary Institution: University of Washington
Hypothesis
Can extracellular administration of BCL2 proteins reduce apoptosis and improve survival in a murine model of sepsis?
Conclusion
Extracellular administration of BCL2 proteins significantly reduces apoptosis in multiple organs and improves survival in mice with sepsis.
Supporting Evidence
- Treatment with rhBCL2A1 significantly improved survival compared to control.
- Apoptosis in the heart and intestine was reduced by 76% and 58% respectively after treatment.
- Endogenous mouse BCL2 protein expression increased in treated mice.
Takeaway
Giving a special protein called BCL2 to sick mice helps them live longer by stopping their cells from dying.
Methodology
Mice were treated with recombinant human BCL2 or BCL2A1 protein before being subjected to sepsis induced by cecal ligation and puncture.
Limitations
The study was conducted in a murine model, which may not fully replicate human sepsis.
Participant Demographics
C57BL/6 and TLR2-null mice were used in the study.
Statistical Information
P-Value
p=0.003
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website